Emergent BioSolutions Inc (EBS)
5.55
+0.28
(+5.31%)
USD |
NYSE |
May 17, 16:00
5.55
0.00 (0.00%)
Pre-Market: 20:00
Emergent BioSolutions 1 Year Total Returns (Daily): -38.61% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -38.61% |
May 16, 2024 | -40.59% |
May 15, 2024 | -38.54% |
May 14, 2024 | -44.66% |
May 13, 2024 | -41.61% |
May 10, 2024 | -59.76% |
May 09, 2024 | -54.95% |
May 08, 2024 | -51.64% |
May 07, 2024 | -50.89% |
May 06, 2024 | -55.58% |
May 03, 2024 | -53.91% |
May 02, 2024 | -60.10% |
May 01, 2024 | -78.24% |
April 30, 2024 | -78.71% |
April 29, 2024 | -78.60% |
April 26, 2024 | -78.64% |
April 25, 2024 | -79.43% |
April 24, 2024 | -78.50% |
April 23, 2024 | -77.92% |
April 22, 2024 | -79.17% |
April 19, 2024 | -80.93% |
April 18, 2024 | -83.00% |
April 17, 2024 | -83.77% |
April 16, 2024 | -83.54% |
April 15, 2024 | -83.29% |
Date | Value |
---|---|
April 12, 2024 | -83.37% |
April 11, 2024 | -83.42% |
April 10, 2024 | -81.99% |
April 09, 2024 | -78.12% |
April 08, 2024 | -78.03% |
April 05, 2024 | -77.70% |
April 04, 2024 | -77.02% |
April 03, 2024 | -76.92% |
April 02, 2024 | -79.15% |
April 01, 2024 | -77.80% |
March 28, 2024 | -71.57% |
March 27, 2024 | -70.77% |
March 26, 2024 | -69.88% |
March 25, 2024 | -68.64% |
March 22, 2024 | -69.06% |
March 21, 2024 | -69.77% |
March 20, 2024 | -68.90% |
March 19, 2024 | -69.70% |
March 18, 2024 | -69.58% |
March 15, 2024 | -74.61% |
March 14, 2024 | -75.77% |
March 13, 2024 | -76.50% |
March 12, 2024 | -75.95% |
March 11, 2024 | -71.10% |
March 08, 2024 | -74.01% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.67%
Minimum
Feb 20 2024
211.8%
Maximum
Aug 05 2020
-22.81%
Average
-46.64%
Median
Oct 13 2021
1 Year Total Returns (Daily) Benchmarks
Avid Bioservices Inc | -40.04% |
Viking Therapeutics Inc | 174.5% |
FibroGen Inc | -93.27% |
Avinger Inc | -58.13% |
RAPT Therapeutics Inc | -80.81% |